Opinion
No. 361, 2017
04-23-2018
ELISHA BALLARD, Plaintiff Below, Appellant, v. TAKEDA PHARMACEUTICALS AMERICA, INC., TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, and ELI LILLY AND COMPANY, Defendants Below, Appellees.
Court Below: The Superior Court of the State of Delaware C.A. No. N16C-10-177 JRJ Before STRINE, Chief Justice; SEITZ, and TRAYNOR, Justices. ORDER
This 23rd day of April 2018, it appears to the Court that the judgment of the Superior Court should be affirmed on the basis of its opinion dated August 7, 2017.
Ballard v. Takeda Pharm. Am., Inc., 2017 WL 3396488 (Del. Super. Ct. Aug. 7, 2017).
NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior Court is hereby AFFIRMED.
BY THE COURT:
/s/ Leo E . Strine, Jr.
Chief Justice